These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 2160312

  • 1. Cisplatin, etoposide, and ifosfamide in non-small cell lung carcinoma. A phase II randomized study with cisplatin and etoposide as the control arm.
    Paccagnella A, Favaretto A, Brandes A, Ghiotto C, Fornasiero A, Volpi A, Pappagallo G, Festi G, Cipriani A, Vinante O.
    Cancer; 1990 Jun 15; 65(12):2631-4. PubMed ID: 2160312
    [Abstract] [Full Text] [Related]

  • 2. [Cisplatin etoposide versus cisplatin/etoposide/ifosfamide combination chemotherapy in small-cell lung cancer: a multicenter randomized controlled study. Hokkaido Study Group of Treatment for Small-Cell Lung Cancer].
    Miyamoto H, Kawakami Y, Arimoto T, Asakawa M, Suzuki A, Fujikane T, Onodera S, Nakabayashi T, Yasuda S, Shimizu T.
    Gan To Kagaku Ryoho; 1991 Jun 15; 18(7):1127-34. PubMed ID: 1647149
    [Abstract] [Full Text] [Related]

  • 3. Phase II study of cisplatin, ifosfamide with mesna, and etoposide (PIE) chemotherapy for advanced non-small cell lung cancer.
    Shirinian M, Lee JS, Dhingra HH, Greenberg J, Hong WK.
    Semin Oncol; 1992 Feb 15; 19(1 Suppl 1):49-53. PubMed ID: 1329212
    [Abstract] [Full Text] [Related]

  • 4. A phase III comparison of etoposide/cisplatin with or without added ifosfamide in small-cell lung cancer.
    Miyamoto H, Nakabayashi T, Isobe H, Akita H, Kawakami Y, Arimoto T, Asakawa M, Suzuki A, Fujikane T, Shimizu T.
    Oncology; 1992 Feb 15; 49(6):431-5. PubMed ID: 1334539
    [Abstract] [Full Text] [Related]

  • 5. [Chemotherapy of non-small cell bronchial cancer with ifosfamide in combination with cisplatin, etoposide or vindesine].
    Drings P, Becker H, Bülzebruck H, Djawid N, Ruchalla E, Stiefel P, Tessen HW.
    Onkologie; 1988 Feb 15; 11 Suppl 2():47-56. PubMed ID: 2851761
    [Abstract] [Full Text] [Related]

  • 6. Experience with ifosfamide combinations (etoposide or DDP) in non-small cell lung cancer.
    Drings P, Abel U, Bülzebruck H, Stiefel P, Kleckow M, Manke HG.
    Cancer Chemother Pharmacol; 1986 Feb 15; 18 Suppl 2():S34-9. PubMed ID: 3028662
    [Abstract] [Full Text] [Related]

  • 7. Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
    Wolf M, Havemann K, Holle R, Gropp C, Drings P, Hans K, Schroeder M, Heim M, Dommes M, Mende S.
    J Clin Oncol; 1987 Dec 15; 5(12):1880-9. PubMed ID: 2824710
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. European experience with ifosfamide in non-small cell lung cancer.
    Drings P.
    Semin Oncol; 1989 Feb 15; 16(1 Suppl 3):22-30. PubMed ID: 2539645
    [Abstract] [Full Text] [Related]

  • 11. A brief intensive cisplatin-based outpatient chemotherapy regimen with filgrastim and megestrol acetate support for advanced non-small cell lung cancer: results of a phase II trial.
    Levitan N, Dowlati A, Craffey M, Tahsildar H, MacKay W, McKenney J, Remick SC.
    Lung Cancer; 1998 Dec 15; 22(3):227-34. PubMed ID: 10048475
    [Abstract] [Full Text] [Related]

  • 12. Etoposide, ifosfamide, and cisplatin in the treatment of advanced non-small cell lung cancer.
    Ardizzoni A, Fusco V, Gulisano M, Pronzato P, Baracco F, Capaccio A, Pastorino G, Nosenzo M, Felletti R, Fabiano F.
    Cancer Treat Rep; 1987 Dec 15; 71(12):1311-2. PubMed ID: 2825994
    [No Abstract] [Full Text] [Related]

  • 13. A phase II study of ifosfamide, cisplatin, etoposide in patients with advanced non-small cell lung cancer: a preliminary report.
    Shepherd FA, Goss PE, Latreille J, Stewart D, Logan D, Evans WK, Maroun J, Warner E.
    Semin Oncol; 1990 Apr 15; 17(2 Suppl 4):19-23. PubMed ID: 2159185
    [Abstract] [Full Text] [Related]

  • 14. [Comparing cisplatin plus etoposide with combination of mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer patients].
    Cok G, Göksel T, Soyer S, Atil H, Güzelant A, Aysan T.
    Tuberk Toraks; 2006 Apr 15; 54(2):161-7. PubMed ID: 16924573
    [Abstract] [Full Text] [Related]

  • 15. Pei regimen: a therapeutic option in small cell lung cancer? A retrospective monoinstitutional analysis of 46 consecutive cases.
    Boni C, Pagano M, Baldi L, Gnoni R, Braglia L, Savoldi L, Zanelli F.
    J Transl Med; 2015 Apr 24; 13():130. PubMed ID: 25903963
    [Abstract] [Full Text] [Related]

  • 16. A phase II study of ifosfamide in combination with etoposide and cisplatin in the treatment of extensive small cell lung cancer.
    Evans WK, Stewart D, Logan D, Maroun J, Goss G, Shepherd FA, Latreille J, Warner E, Dahrouge S.
    Semin Oncol; 1992 Dec 24; 19(6 Suppl 12):51-6. PubMed ID: 1336622
    [Abstract] [Full Text] [Related]

  • 17. Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico Campano.
    Comella P, Frasci G, De Cataldis G, Panza N, Cioffi R, Curcio C, Belli M, Bianco A, Ianniello G, Maiorino L, Della Vittoria M, Perchard J, Comella G.
    Br J Cancer; 1996 Dec 24; 74(11):1805-11. PubMed ID: 8956797
    [Abstract] [Full Text] [Related]

  • 18. Long-term results of neoadjuvant ifosfamide, cisplatin, and etoposide combination in locally advanced non-small-cell lung cancer.
    Pujol JL, Hayot M, Rouanet P, Le Chevalier T, Michel FB.
    Chest; 1994 Nov 24; 106(5):1451-5. PubMed ID: 7956400
    [Abstract] [Full Text] [Related]

  • 19. Pilot study with cisplatin, ifosfamide, and etoposide in advanced non-small-cell lung carcinoma.
    Bidoli P, Spinazzè S, Santoro A, Casali P, Bedini AV, Guzzon A.
    Am J Clin Oncol; 1990 Oct 24; 13(5):424-6. PubMed ID: 2171319
    [Abstract] [Full Text] [Related]

  • 20. [Use of etoposide, ifosfamide and cisplatin (EIP) for treatment of inoperable non-small cell lung cancer].
    Czownicki Z, Pasz P, Michałek A, Zientek J, Zientek A, Koźlik H.
    Pneumonol Alergol Pol; 2000 Oct 24; 68(9-10):411-6. PubMed ID: 11276971
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.